Verition Fund Management LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Verition Fund Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $812,421 - $894,015	900 Added 32.14%	3,700 $3.56 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $1.32 Million - $1.5 Million	1,700 Added 154.55%	2,800 $2.46 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $761,695 - $928,807	1,100 New	1,100 $905,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $286,985 - $362,160	500 New	500 $344,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $238,048 - $279,372	400 Added 16.67%	2,800 $1.96 Million
Q4 2021 May 03, 2022	BUY	$543.48 - $670.97 $1.3 Million - $1.61 Million	2,400 New	2,400 $1.52 Million

1,463

84.5M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.